search - Mayo Clinic Laboratories

Providing a comprehensive genetic evaluation for patients with a personal or family history suggestive of hereditary hemolytic anemias, including red blood cell (RBC) membrane/hydration disorders, RBC enzymopathies, and congenital...

ADALP - Overview: Adalimumab Quantitative with Antibody, Serum

Therapeutic drug monitoring of adalimumab concentration and antibody levels

QNKS - Overview: Natural Killer (NK)/Natural Killer T-Cell Subsets, Quantitative, Blood

Quantitation of the major natural killer (NK)-cell subsets relative to total NK cells (NK cell subsets) or total lymphocytes (NK T cells) Assessment in the following clinical contexts: HIV, primary immune deficiencies with NK cell...

TTBS - Overview: Testosterone, Total and Bioavailable, Serum

Recommended second-level test for suspected increases or decreases in physiologically active testosterone: -Assessment of androgen status in cases with suspected or known sex hormone-binding globulin binding abnormalities -Assessment of...

GPSYW - Overview: Glucopsychosine, Blood

Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified Diagnosis and monitoring of patients with Gaucher disease using whole blood specimens Supporting the biochemical diagnosis of...

MBLF - Overview: Mannan Binding Lectin Complement Pathway, Functional, Serum

Investigating recurrent meningococcal disease in young children Investigating recurrent or severe infections in adults Investigating glomerular kidney diseases Additionally, deficiencies or dysregulation within the complement system may...

CDGN - Overview: Congenital Disorders of N-Glycosylation, Serum

Screening for N-linked congenital disorders of glycosylation Providing information on specific structural oligosaccharide abnormalities to potentially direct further genetic testing

HSMP - Overview: Hepatosplenomegaly Panel, Plasma

As a component to the initial evaluation of a patient presenting with hepatosplenomegaly, using plasma specimens This test is not useful for the identification of carriers. This test should not be used as a monitoring tool for patients...

GPSYP - Overview: Glucopsychosine, Plasma

Second-tier test when newborn screening results with reduced beta-glucosidase (GBA) activity are identified Diagnosis and monitoring of patients with Gaucher disease using plasma specimens Supporting a biochemical diagnosis of Gaucher...

ZW214 - Overview: Miscellaneous Ocular Immunology Laboratory OHSU

Miscellaneous Ocular Immunology Laboratory OHSU

ZW278 - Overview: Miscellaneous University of Washington Medical Center-Clinical Immunology Lab

Miscellaneous University of Washington Medical Center-Clinical Immunology Lab

ZW2 - Overview: Miscellaneous MML Referral Test 2

Miscellaneous MML Referral Test 2

ZW204 - Overview: Misc Cincinnati Childrens Hospital Medical Center

Misc Cincinnati Childrens Hospital Medical Center

ZW266 - Overview: Miscellaneous Machaon Diagnostics

Miscellaneous Machaon Diagnostics

ZW149 - Overview: Misc Monogram Biosciences, Inc.

Misc Monogram Biosciences, Inc.

ZW196 - Overview: Misc National Jewish Health Mycobacteriology Test

Misc National Jewish Health Mycobacteriology Test

ZW172 - Overview: Miscellaneous Center for Genetic Testing at St. Francis

Miscellaneous Center for Genetic Testing at St. Francis

ZW221 - Overview: Miscellaneous Baylor Medical Genetics Laboratories

Miscellaneous Baylor Medical Genetics Laboratories

ZW175 - Overview: Miscellaneous Kennedy Krieger Institute

Miscellaneous Kennedy Krieger Institute

ZW194 - Overview: Miscellaneous Prevention Genetics Lab

Miscellaneous Prevention Genetics Lab

ZW246 - Overview: Miscellaneous Childrens Hospital of Colorado Testing

Miscellaneous Childrens Hospital of Colorado Testing

ZW57 - Overview: Miscellaneous Esoterix Coagulation

Miscellaneous Esoterix Coagulation

ZW85 - Overview: Miscellaneous National Jewish Health

Miscellaneous National Jewish Health

Site Search

Second-Tier Assay for MPS I Newborn Screening Shows Remarkable Reduction of False Positives - Insights...

Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder that typically presents with progressive multisystem involvement in early childhood. This condition results from the deficiency of the enzyme...

webinar on implementation of high-sensitivity troponin I assay - Insights

Cardiovascular Diseases, will be presenting a webinar on the implementation of a high-sensitivity troponin I assay. The webinar will be held February 13 from 1:00-2:00 p.m. eastern....

Should I Stay or Should I Go? - Insights

In this episode of “Lab Medicine Rounds,” host Justin Kreuter, M.D., and Rondell Graham, M.B.B.S., delve into the critical decisions involved in contemplating a role on the staff at the institution where you receive your training.

often oversimplified & misunderstood technology--Part I

In the last decade, genetic testing has evolved from single-gene Sanger based assays to much more complex next-generation sequencing (NGS) based assays.

inform novel treatments for kidney stones - Part I - Insights

A collaborative study between Mayo Clinic and the University of Illinois debunked the previous consensus about how kidney stones grow.

More Results